PALVELLA THERAPEUTICS, INC.
PVLACIK 0001583648 · Pharmaceutical Preparations · Nasdaq
- PIERIS PHARMACEUTICALS, INC. (until 2024-12-12)
- Marika Inc. (until 2014-12-18)
Revenue (TTM)
$34.84M
+60.2% YoY
Q1 May 2026
Net Income (TTM)
−$44.77M
−139.3% YoY
Q1 May 2026
EPS Diluted (TTM)
−$3.83
+52.6% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-121.0%
Q1 May 2026
Net Margin
-128.5%
Q1 May 2026
Free Cash Flow (TTM)
−$30.2M
Q1 May 2026
Cash
$206.39M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
14.34M sh
Q1 May 2026